Jukka T. Puolivali
Charles River
Kuopio, Finland
Kuopio, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Targeting a Novel Site in Exon 51 with Antisense Oligonucleotides Induces Enhanced Exon Skipping in a Mouse Model of Duchenne Muscular Dystrophy.
Journal: Nucleic acid therapeutics
Published: February 07, 2025
BMN 351-Induced Exon Skipping and Dystrophin Expression in Skeletal and Cardiac Muscle Lead to Preservation of Motor Function in a Mouse Model of Exon 51 Skip-Amenable Duchenne Muscular Dystrophy.
Journal: Nucleic acid therapeutics
Published: February 07, 2025
Physiological and behavioural implications of the portosystemic shunt in C57Bl/6J mice.
Journal: The Journal of physiology
Published: July 05, 2024
Next Generation Exon 51 Skipping Antisense Oligonucleotides for Duchenne Muscular Dystrophy.
Journal: Nucleic acid therapeutics
Published: April 10, 2023
Vertigoheel promotes rodent cognitive performance in multiple memory tests.
Journal: Frontiers in neuroscience
Published: March 09, 2023
Detailed genetic and functional analysis of the hDMDdel52/mdx mouse model.
Journal: PloS one
Published: May 14, 2020
Using a State-of-the-Art Toolbox to Evaluate Molecular and Functional Readouts of Antisense Oligonucleotide-Induced Exon Skipping in mdx Mice.
Journal: Nucleic acid therapeutics
Published: December 11, 2019
A multimodal approach to identify clinically relevant biomarkers to comprehensively monitor disease progression in a mouse model of pediatric neurodegenerative disease.
Journal: Progress in neurobiology
Published: June 19, 2019
Suppression of Mutant Protein Expression in SCA3 and SCA1 Mice Using a CAG Repeat-Targeting Antisense Oligonucleotide.
Journal: Molecular therapy. Nucleic acids
Published: May 21, 2019
Impaired Performance of the Q175 Mouse Model of Huntington's Disease in the Touch Screen Paired Associates Learning Task.
Journal: Frontiers in behavioral neuroscience
Published: July 09, 2018
Last Updated: 09/26/2026